Podcasts about General surgery

Join the Behind the Knife Surgical Oncology Team as we discuss the two key studies investigating optimal management strategies of neuroendocrine tumors of the small bowel. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center - Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. - Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. - Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Learning Objectives: In this episode we review two important papers that discuss optimal management strategies of neuroendocrine tumors (NET) of the small bowel.  The first paper by Singh and colleagues discusses the NETTER-2 trial investigating the role of radioligand therapy for NET as a first-line treatment.  The second article by Maxwell et all challenges surgical dogma regarding optimal debulking cutoffs for debulking of NET. Links to Papers Referenced in this Episode: 1.     Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, Ferone D; all the NETTER-2 Trial Investigators. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5. PMID: 38851203. https://pubmed.ncbi.nlm.nih.gov/38851203/ 2.     Maxwell JE, Sherman SK, O'Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery. 2016 Jan;159(1):320-33. doi: 10.1016/j.surg.2015.05.040. Epub 2015 Oct 9. PMID: 26454679; PMCID: PMC4688152. https://pubmed.ncbi.nlm.nih.gov/26454679/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode I am starting a series of videos in Pediatric Surgery. Here also like General Surgery it's going to be a problem based teaching. So to begin with I will discuss all the surgical causes for Neonatal Respiratory Distress. In the first episode it is Esophageal Atresia with or without TEF. I have discussed the embryological basis, clinical features, diagnostic investigations, associated anomalies, pre-op preparation, treatment, post-op care, prognosis of EA/TEF. Anyone interested in child care may find it interesting.

സർജറി എന്ന് കേൾക്കുമ്പോഴേ ഭയക്കുന്നവരാണ് ബഹുഭൂരിപക്ഷം വ്യക്തികളും.എന്നാൽ പലപ്പോഴും ഈ അമിത ഭയത്തിന്റെ ആവശ്യവും ഉണ്ടാവാറില്ല.കാരണം വ്യക്തമായ ആരോഗ്യ അറിവുകൾ ഈ അവസ്ഥയെ മറികടക്കാൻ സഹായിക്കും.സർജറി സംബന്ധിച്ച ഇത്തരം സംശയങ്ങളെ കുറിച്ചുള്ള വിശദ അറിവുകളുമായി ആരോഗ്യ മംഗളത്തിൽ ചേരുന്നു തെള്ളകം മിതേര ഹോസ്പിറ്റൽ General and Laparoscopic Surgeon Dr.Josna.K.Jose

In this episode of Surgical Readings, Dr. Rick Greene leads an insightful discussion with Drs. Carla Fisher and Kay Yoon-Flannery on the diagnosis and management of breast disease. The conversation explores a range of topics, including both benign and malignant breast conditions. A comprehensive review of breast cancer is presented, covering management of the primary lesion, evolving approaches to axillary staging and therapy, the use of genetic and genomic testing, and the value of chemotherapy and immunotherapy. Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings #SRGS

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “Computer-Aided Design and Manufacturing in Free Fibula Reconstruction of the Mandible: Comparison of Long-Term Outcomes with the Conventional Technique” by Bengur, Humar, Saadoun, et al.  Read the article for FREE: https://bit.ly/CADCAMRecon Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

Dr. Jennifer Wargo is an Associate Professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center and a Stand Up To Cancer researcher. Jennifer is a physician scientist, and this means she splits her time between providing care to patients and doing research to find better ways of treating disease. Specifically, Jennifer performs surgeries and treats patients one day each week. She spends the rest of her week studying how to better treat patients with cancer and how cancer may ultimately be prevented. When she's not doing research or treating patients, Jennifer enjoys spending quality time with her family. Some of their favorite activities include going for walks, biking, hiking, and visiting the beach. Jennifer also likes to explore her creative side through art and photography, as well as to be active through running, biking, yoga, and surfing. She received her A.S. degree in nursing and B.S. degree in biology from Gwynedd-Mercy College. Afterwards, Jennifer attended the Medical College of Pennsylvania where she earned her M.D. Jennifer completed her Clinical Internship and Residency in General Surgery at Massachusetts General Hospital. Next, Jennifer was a Research Fellow in Surgical Oncology at the University of California, Los Angeles. She then accepted a Clinical Residency in General Surgery at Massachusetts General Hospital. From 2006-2008, Jennifer was a Clinical Fellow in Surgical Oncology at the National Cancer Institute of the National Institutes of Health. She then served on the faculty at Massachusetts General Hospital and Harvard University. In 2012, Jennifer received her MMSc. degree in Medical Science from Harvard University. Jennifer joined the faculty at The University of Texas MD Anderson Cancer Center in 2013. She is Board Certified by the American Board of Surgery, and she has received numerous awards and honors throughout her career. These have included the R. Lee Clark Prize and Best Boss Award from the MD Anderson Cancer Center, the Rising STARS and The Regents' Health Research Scholars Awards from the University of Texas System, the Outstanding Young Investigator and Outstanding Investigator Awards from the Society for Melanoma Research, as well as a Stand Up To Cancer Innovative Research Grant for her microbiome work. She has also received other awards for excellence in teaching, research, and patient care. In our interview, Jennifer shares more about her life and science.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “Legislative Impact and Persistent Disparities: Postmastectomy Breast Reconstruction Rates in the United States among 224,506 Patients” by Schafer, Ho, Potoczak, et al. Read the article for FREE: https://bit.ly/LegislativeReconRate Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

Cancer is among the most common and feared diseases in the modern world. Dr. Selwyn Vickers—president and CEO of Memorial Sloan Kettering Cancer Center—joins host Mark Labberton to discuss how precision oncology, data, and faith are transforming cancer treatment. A distinguished cancer surgeon and pancreatic cancer researcher, Vickers explains how groundbreaking advances in genomics, immunotherapy, and AI are transforming once-lethal diagnoses into survivable and even chronic conditions. Together, they explore not only the cutting-edge science of cancer care but also the spiritual, emotional, and social dimensions that affect every patient and caregiver. Resonating with themes of suffering, hope, and resurrection, this conversation offers clarity, compassion, and courage for all who are affected by cancer—from those newly diagnosed, to medical professionals, to grieving families and curious listeners. Episode Highlights “We're getting to a point where we will, in the next five to seven years, have a much better chance to cure people—and to make pancreatic cancer a chronic illness.” “We are in what's somewhat coined the golden age of cancer research.” “Cancer is a disease that creates an existential threat in ways no other illness does.” “If a tumour forms, it means your body's immune system has made a social contract with the cancer.” “We changed the diagnosis in 10–12 percent of the patients who come to us—sometimes from cancer to no cancer.” “Cancer care is a team sport. And our patients often inspire us more than we help them.” Helpful Links & Resources Memorial Sloan Kettering Cancer Center BioNTech – creators of mRNA vaccines for COVID and cancer CAR T-Cell Therapy Overview (Cancer.gov) Tim Keller on cancer and hope Emma Thompson's Wit (HBO) BRCA1 and BRCA2 Genes and Cancer Risk MSK-IMPACT: Next-Gen Tumor Profiling About Selwyn Vickers Selwyn M. Vickers, MD, FACS, is the president and CEO of Memorial Sloan Kettering Cancer Center (MSK) and the incumbent of the Douglas A. Warner III Chair. He assumed the role on September 19, 2022. Vickers is an internationally recognized pancreatic cancer surgeon, pancreatic cancer researcher, and pioneer in health disparities research. He is a member of the National Academy of Medicine and the Johns Hopkins Society of Scholars. He has served on the Johns Hopkins School of Medicine Board of Trustees and the Johns Hopkins University Board of Trustees. Additionally, he has served as president of the Society for Surgery of the Alimentary Tract and the Southern Surgical Association. Vickers is the immediate past president of the American Surgical Association. He also continues to see patients. In 1994, he joined the faculty of the University of Alabama at Birmingham (UAB) as an assistant professor in the Department of Surgery, where he was later appointed to professor and the John H. Blue Chair of General Surgery. In 2006, Vickers left UAB to become the Jay Phillips Professor and Chair of the Department of Surgery at the University of Minnesota Medical School. Born in Demopolis, Alabama, Vickers grew up in Tuscaloosa and Huntsville. He earned baccalaureate and medical degrees and completed his surgical training (including a chief residency and surgical oncology fellowship) at the Johns Hopkins University. Vickers completed two postgraduate research fellowships with the National Institutes of Health and international surgical training at John Radcliffe Hospital of Oxford University, England. Vickers and his wife, Janice, who is also from Alabama, have been married since 1988. They have four children. Show Notes The ongoing threat and fear of cancer How Selwyn Vickers got into medicine Pancreatic cancer: Vickers's expertise “We are in what's somewhat coined the golden age of cancer research.” Sequencing the human genome “Is there a drug that might target the mutation that ended up creating your cancer?” Cancer as both a medical and existential diagnosis The revolution of precision oncology through human genome sequencing ”It takes a billion cells to have a one centimetre tumor.” Immunotherapy: checkpoint inhibition, CAR T-cell therapy, and vaccines Cellular therapy:   ”Taking a set of their normal cells and re-engineering them to actually go back and target and attack their tumors. … We've seen patients who had initially a 30 percent chance of survival converted to an 80 percent chance of survival.” “We know in many tumours there's something called minimal residual disease.” “Immunizing yourself against cancer is a significant future opportunity.” Managing the power of data with AI and computational oncology Cancer-care data explosion: the role of computational oncologists Cancer vaccines: breakthrough mRNA treatment for pancreatic cancer ”Didn't ultimately win. We had to suffer through her losing her life, but was so appreciative that she got much more than the six months she was promised.” Tumour misdiagnoses and the importance of specialized expertise Pancreatic cancer challenges: immune cloaking and late-stage detection In the past, one in four would die from the operation for removing pancreatic cancer Long-term survival Future of cancer detection: AI-based medical record analysis and blood biopsies More accurate blood tests to confirm conditions Using AI to select those who are high-risk for cancer Pastor Tim Keller died of pancreatic cancer. In the past, “your doctor … helped you learn how to die.” ”[God's] given man the privilege to discover those things that have been hidden. And over time we've gradually uncovered huge opportunities to impact people's lives.” The state of breast cancer research and treatment “If you get the diagnosis of breast cancer, you have a 90 percent chance to survive and beat it over a five-year period of time.” ”In general, we're in a great state of understanding how to treat breast cancer, how to detect it early, and then have selective and targeted mechanisms to prevent it from coming back.” Prostate cancer research and treatment Theranostics: using a specific antibody to target cancer cells specifically Pediatric cancer:  ”We actually treat more children for cancer than any hospital in America now, but in general, the survival for pediatric cancers is greater than 80 percent.” Emotional, psychological, and spiritual toll of cancer: importance of psycho-oncology How Sloan Kettering developed psycho-oncology to help cancer patients with mental and spiritual health Personal story: how a cafeteria worker empowers patients through food choices “We give back to them the right to choose what they get to have on their tray.” Cancer treatment is a team sport. Wit (film, Broadway play)—actress Emma Thompson plays a cancer patient studying the work of John Donne on death Socioeconomic and racial disparities in cancer care outcomes The healing role of community, support teams, and compassionate listening The importance of listening to cancer patients who are preparing to die The spiritual courage of patients and the transformative power of faith “Our patients often help us. We see the grace with which they often handle that journey.” The inspiration behind becoming a doctor: family legacy and human impact Terminal care: the sacred responsibility of walking with patients to the end Cancer research and treatment as a Christian vocation and expression of humanity Production Credits

Raeann Wilson was born in Cabot, AR. As a breast cancer survivor, IV therapy was an integral part of Raeann's recovery, and she became passionate about giving the same level of care to other post-operation patients. As the surgical coordinator at Shewmake Plastic Surgery, Raeann has extensive knowledge in surgical processes and patient care. This all gave her the skill and inspiration to create Zen Infusion, offering mobile, on-demand IV infusion therapy that serves a number of needs for the people of Central Arkansas. Kris Shewmake, M.D., FACS was born in Pine Bluff, AR. He earned his bachelor's degree in biology from Hendrix College in Conway and a master's degree in natural science from the University of Arkansas at Fayetteville. He received his medical degree from UAMS, where he also completed a residency in general surgery. He was president of his class and elected into the Alpha Omega Alpha Medical Honor Society (top 10% of the class). His eight years of surgical training after medical school included a General Surgery residency at the University of Arkansas for Medical Sciences (UAMS) Medical Center and a Plastic and Reconstructive Surgery residency in Dallas at the University of Texas-Southwestern Medical Center. Dr. Shewmake entered private practice in 1996 and was named Best Plastic Surgeon in Arkansas by his colleagues in 1999 and 2009.

In this episode of Deep Cuts: Exploring Equity in Surgery, Dr. Carmelle Romain and Dr. Kylie Callier provide an overview of the field of pediatric surgery. We cover key aspects of pediatric surgery, from common pediatric conditions to the factors that attract surgeons to the subspecialty. We also examine which populations of children lack access to surgery, and the reasons behind these barriers.  Finally, we highlight what the University of Chicago is doing to improve access for children and parents in Chicago's South Side. Dr. Carmelle Romain is a pediatric surgeon and Assistant Professor in the Department of General Surgery. She attended medical school at Brown University and completed her residency and fellowship training at Vanderbilt University and Miami Children's Hospital. In addition to her clinical practice, Dr. Romain is an active researcher examining how telehealth can expand access for pediatric patients.Dr. Kylie Callier is a 3rd-year surgery resident at UChicago Medicine and a fellow at the Maclean Center for Clinical Medical Ethics. She is an aspiring pediatric surgeon and attended medical school at Texas Tech University. Her research interests include pediatric trauma and pediatric ECMO, a life-supporting treatment for critically ill children with heart and/or lung failure. Deep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our executive producer is Tony Liu. Our senior producers are Alia Abiad, Caroline Montag, and Chuka Onuh. Our production team includes Megan Teramoto, Ria Sood, Ishaan Kumar, and Daniel Correa Buccio. Our senior editor and production coordinator is Nihar Rama. Our editorial team also includes Beryl Zhou. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen.A special thanks this week to Dr. Jeffrey Matthews — for his leadership, vision, and commitment to caring for the most vulnerable in our communities. Let us know — what have you most enjoyed about our podcast. Where do you see room for improvement? You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

We got the gang together (minus John, who is on mission).  Today, we are talking about diverticulitis with super expert Scott Steele.  Scott walks Jason, Patrick, and Kevin through the nuances of modern-day management of diverticulitis.   We cover laparoscopic lavage, review decision making for surgical resection after drainage, and discuss the evolving role of antibiotics in uncomplicated cases. Surgical techniques, including resection boundaries and the consideration of diverting ostomies in emergent situations, are also reviewed.  DOMINATE THE COLON! Hosts Scott Steele, MD: @ScottRSteeleMD Scott is the Rupert B. Turnbull MD Endowed Chair in Colorectal Surgery and Chairman of Colorectal Surgery at Cleveland Clinic in Cleveland, OH. A graduate of the United States Military Academy at West Point, he was an active duty Army officer for over 20 years, serving as the Chief of Colorectal Surgery at Madigan Army Medical Center. He also received his MBA from Case Western University Weatherhead School of Business and Management. Patrick Georgoff, MD: @georgoff Patrick Georgoff is an Acute Care Surgeon at Duke University.  He went to medical school at the University of Pennsylvania, completed General Surgery residency and Surgical Critical Care fellowship at the University of Michigan, and a Trauma Surgery fellowship at the University of Texas in Houston.  His clinical practice includes the full spectrum of Acute Care Surgery in addition to elective hernia surgery.  Patrick is the Associate Program of the General Surgery Residency and associate Trauma Medical Director at Duke. Kevin Kniery, MD: @Kniery_Bird Kevin is a vascular surgeon at Brooke Army Medical Center. He completed his undergraduate degree at the United States Military Academy in West Point, medical school at Tulane University, general surgery residency at Madigan Army Medical Center, and vascular fellowship at Cornell and Columbia. Jason Bingham, MD: @BinghamMd Jason is a general and bariatric surgeon at Madigan Army Medical Center. He also serves as the Director of Research and Associate Program Director for the general surgery residency program. He received his undergraduate degree from New York University and medical degree at the Uniformed Services University of Health Sciences. He is a medical officer in the US Army with several combat deployments under his belt. Jason's research efforts focus on the management of hemorrhagic shock, trauma induced coagulopathy, and ischemia-reperfusion injury. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “The Financial Impact of a Cosurgeon in Breast Microsurgery” by DeVito, Ke, Park, et al. Read the article for FREE: https://bit.ly/CosurgeonFinance Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

Drugs don't care where you grew up, went to school, or what you majored in. When you develop destructive habits, though, you have an opportunity to turn your life around by developing new, healthier habits. Dr. Jason Giles discusses the road to recovery from substance use disorders. Dr. Giles is a graduate of University of California Berkeley. He earned a degree in molecular biology and then earned his medical degree from UC Davis. Dr. Giles completed an internship in General Surgery, residency in Anesthesiology and Pain Medicine, and earned board certifications in Anesthesiology and Addiction Medicine. He was a cardiac anesthesiologist and pain specialist before devoting his full attention to addiction medicine starting in 2005. He is the author of a new book, “The Addiction Doctors Manual for Behavioral Health Technicians: What to Do When You Don't Know What to Do” and a previous book, “Outsmart Your Addiction.” His books can be found at https://www.amazon.com/Addiction-Doctors-Manual-Behavioral-Technicians/dp/1735081914 and https://www.amazon.com/Outsmart-Your-Addiction-Powerful-Developed/dp/1735081906 Dr. Giles can be reached at https://addictiondoctors.com/ The views and opinions of the guests on this podcast are theirs and theirs alone and do not necessarily represent those of the host, Westwords Consulting or the Kenosha County Substance Abuse Coalition. We're always interested in hearing from individuals or organizations who are working in substance use disorder treatment or prevention, mental health care and other spaces that lift up communities. This includes people living those experiences. If you or someone you know has a story to share or an interesting approach to care, contact us today! Follow us on Facebook, LinkedIn, and YouTube. Subscribe to Our Email List to get new episodes in your inbox every week!

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue:   “The Financial Impact of a Cosurgeon in Breast Microsurgery” by DeVito, Ke, Park, et al.   “Legislative Impact and Persistent Disparities: Postmastectomy Breast Reconstruction Rates in the United States among 224,506 Patients” by Schafer, Ho, Potoczak, et al.   “Computer-Aided Design and Manufacturing in Free Fibula Reconstruction of the Mandible: Comparison of Long-Term Outcomes with the Conventional Technique” by Bengur, Humar, Saadoun, et al.   Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery.   READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection   The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

  Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Dr. Stanley Liu (“Leo”) received his undergraduate education from Stanford University. He completed DDS and MD degrees, with General Surgery internship and Oral & Maxillofacial Surgery residency, from the University of California – San Francisco (UCSF). After Sleep Surgery Fellowship at Stanford Medical School in 2014, he was appointed faculty in the Department of Otolaryngology until 2023. He rose to the rank of Associate Professor, and Director of the Sleep Surgery Fellowship. Concurrently, he was a Preceptor of the Oculoplastic Surgery Fellowship and held a courtesy appointment to the Division of Plastic & Reconstructive Surgery.  In February 2024, he joined Nova Southeastern University as the Chair of the Department of Oral & Maxillofacial Surgery, and Assistant Dean of Hospital Affairs. Dr. Liu is a Fellow of the American College of Surgeons (FACS), and the American College of Oral & Maxillofacial Surgeons. He has been a Howard Hughes Medical Institute (HHMI) Scholar, and Stanford Biodesign Faculty Fellow. He serves on the board or executive positions of the California Sleep Society (CSS), American Academy of Physiologic Medicine & Dentistry (AAPMD), and the World Dentofacial Sleep Society (WDSS). He is a consultant member in the sleep section of the American Academy of Otolaryngology – Head & Neck Surgery (AAO-HNS). Dr. Liu's clinical and research focus are on surgical approaches to obstructive sleep apnea. With his surgical mentor and sleep surgery pioneer, Dr. Robert Riley, the Stanford Sleep Surgery approach was updated to integrate drug-induced sleep endoscopy (DISE), nasal surgery including maxillary expansion (DOME), pharyngeal surgery (UPPP), hypoglossal nerve stimulation (HGNS), and maxillomandibular advancement (MMA).  His bibliography lists over 90 journal articles and 20 book chapters. He has been a Grand Rounds speaker at academic programs including UCSF, Northwestern, OHSU, LSU, and Stanford. He has been a Keynote Speaker for preeminent sleep and surgery meetings, including the 33rd SLEEP in 2019, and World Sleep in 2023.

In today's episode, Dr. Mitchell Posner, Dr. Sarah Shubeck, and Dr. Jelani Williams on the University of Chicago Medicine's new Comprehensive Cancer Center. Scheduled to open in 2027, the new center is a seven-floor, 575,000-square-foot building planned to have 80 private beds and 90 consultation and outpatient rooms. At the moment, the center is anticipated to see 200,000 outpatient visits and 5000 inpatient admissions annually. This would be the city of Chicago's first freestanding cancer pavilion.How will we ensure that this new center prioritizes the community's needs? In Chicago's South Side, cancer death rates are twice the national average, and cancer is also the second-leading cause of death on the South Side behind heart disease. In this conversation, you'll hear about the center's development, what patients can expect, and most importantly, the Department of Surgery's commitment to ensure the cancer center supports those who are most vulnerable. Dr. Mitchell Posner is the Thomas D. Jones Distinguished Service Professor of Surgery, Chief of the Section of General Surgery, and the Chief Clinical Officer of the University of Chicago Medicine Comprehensive Cancer Center. From clinical trials for cancer treatment to his more than 250 articles, abstracts, and book chapters, Dr. Posner is a leading authority in the management of upper gastrointestinal cancers. He is frequently voted among the country's best doctors. He is the past president of the Society of Surgical Oncology. He is deputy editor of the Annals of Surgical Oncology and section editor for the gastrointestinal cancer section of the journal Cancer. He served as chairman of the Gastrointestinal Committee of the American College of Surgeons Oncology Group (ACOSOG).Dr. Sarah Shubeck is an Assistant Professor in the Department of General Surgery. She is a Breast Surgical oncologist specializing in breast surgery, cancer, and benign disease treatment. In addition to her clinical practice, Dr. Shubeck's research has been published in many journals including Cancer, JAMA Surgery, and Annals of Surgical Oncology.Dr. Jelani Williams is a 5th-year general surgery resident at the University of Chicago. He is an aspiring surgical oncologist and attended the Eastern Virginia Medical School. He has published research on predictive models and surgery for metastatic pancreatic neuroendocrine tumors as well as the use of machine learning to distinguish benign and malignant thyroid nodules amongst other topics. Deep Cuts: Exploring Equity in Surgery comes to you from the Department of Surgery at the University of Chicago, which is located on Ojibwe, Odawa and Potawatomi land.Our executive producer is Tony Liu. Our senior producers are Alia Abiad, Caroline Montag, and Chuka Onuh. Our production team includes Megan Teramoto, Ria Sood, Ishaan Kumar, and Daniel Correa Bucio. Our senior editor and production coordinator is Nihar Rama. Our editorial team also includes Beryl Zhou and Julianna Kenny-Serrano. The intro song you hear at the beginning of our show is “Love, Money Part 2” from Chicago's own Sen Morimoto off of Sooper Records. Our cover art is from Leia Chen.A special thanks this week to Dr. Jeffrey Matthews — for his leadership, vision, and commitment to caring for the most vulnerable in our communities. Let us know — what have you most enjoyed about our podcast. Where do you see room for improvement? You can reach out to us on Instagram @deepcutssurgery. Find out more about our work at deepcuts.surgery.uchicago.edu.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Brad Hill, MD, discuss the following articles from the March 2025 issue: “Cost Comparison of Digital Nerve Repair Techniques” Hu, Williams, Kammien, et al. Read the article for FREE: https://bit.ly/DNRCostComparison Special guest, Brad Hill, MD, completed combined residency training in General Surgery and Plastic and Reconstructive Surgery at New York University, followed by a Fellowship in Hand and Upper Extremity Surgery at the Curtis National Hand Center. Dr Hill currently serves as the Director of Hand and Peripheral Nerve Surgery Education at Vanderbilt University Medical Center. He is an avid educator and guest on several other national medical podcasts. READ the articles discussed in this podcast as well as free related content: https://bit.ly/March25JCCollection

If you've ever faced the need for surgery, you know how important it is to have a skilled and compassionate team by your side. That's why Aultman General Surgery in Canton, Ohio, is proud to provide top-tier surgical care with a team of experienced surgeons who put patient well-being first. On a recent episode of the Health Matters podcast, hosted by Medicine Center Pharmacy, we had the privilege of speaking with Dr. Elsworth Beach, Dr. Steven Kelly, and Dr. Jay Patibandla—three outstanding surgeons from Aultman General Surgery. They shared insights on the range of surgical services available to patients in our community and what makes Aultman's approach to surgery unique. https://www.medshoprx.com/blog/surgical-frontiers-inside-aultmans-state-of-the-art-general-surgery-care

Shaneeta Johnson, MD, is an Associate Professor of Surgery, Director of Minimally Invasive, Robotic, and Bariatric Surgery, and Program Director, General Surgery Residency Program at Morehouse School of Medicine and Grady Hospital in Atlanta, Georgia. She is also a Senior Fellow of Global Health Equity in the Satcher Health Leadership Institute. She is an experienced surgeon, clinician, educator, philanthropist, and researcher. Shaneeta received her education and surgical training at Johns Hopkins University, Loma Linda University School of Medicine, Howard University Hospital, The Cleveland Clinic and Brandeis. She is a Fellow of the American College of Surgeons, the American Society of Metabolic and Bariatric Surgeons, and the International College of Surgeons. She is board certified in both General Surgery and Obesity Medicine. She has been appointed to leadership positions within state, national, and international organizations and committees.Shaneeta is passionate about furthering health equity and eliminating disparities. She has been involved and/or spearheaded national and international initiatives to improve health equity. She is a sought-after speaker whose expertise has afforded her invitations to speak both nationally and internationally. She is a recipient of the NMA Emerging Leader Trailblazer Award, American College of Surgeons Claude Organ Traveling Fellowship, Atlanta Business Chronicle 40 under 40 award, 2020 Women who Mean Business Award, and the 2019 Outstanding Atlanta award. In her spare time, she enjoys spending time with family, traveling, running, and water sports.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Brad Hill, MD, discuss the following articles from the March 2025 issue: “Eaton-Littler Ligament Reconstruction in Thumb Carpometacarpal Joint Instability: Outcomes and Prognostic Factors in 74 Patients” by Nieuwdrop, Jongen, Hundepool, et al. Read the article for FREE: https://bit.ly/EatonLittLigamen Special guest, Brad Hill, MD, completed combined residency training in General Surgery and Plastic and Reconstructive Surgery at New York University, followed by a Fellowship in Hand and Upper Extremity Surgery at the Curtis National Hand Center. Dr Hill currently serves as the Director of Hand and Peripheral Nerve Surgery Education at Vanderbilt University Medical Center. He is an avid educator and guest on several other national medical podcasts. READ the articles discussed in this podcast as well as free related content: https://bit.ly/March25JCCollection

In the second episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is once again joined by Drs. John Stewart and Prakash Pendalai to discuss the important features of head and neck malignancies, benign and malignant gynecologic conditions, and principles of palliative care for patients with cancer. Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings #SRGS

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Brad Hill, MD, discuss the following articles from the March 2025 issue: “Effect of Tourniquet-Related Nerve Ischemia on Response to Handheld Nerve Stimulation in Ulnar Nerve Transposition” by Brogan, Lee, Beamer, and Dy. Read the article for FREE: https://bit.ly/IschemiaNerveStim Special guest, Brad Hill, MD, completed combined residency training in General Surgery and Plastic and Reconstructive Surgery at New York University, followed by a Fellowship in Hand and Upper Extremity Surgery at the Curtis National Hand Center. Dr Hill currently serves as the Director of Hand and Peripheral Nerve Surgery Education at Vanderbilt University Medical Center. He is an avid educator and guest on several other national medical podcasts. READ the articles discussed in this podcast as well as free related content: https://bit.ly/March25JCCollection

In this episode, we talk with Dr. Anusha Pasumarthi, MD. Dr. Pasumarthi is currently in her second and final year of a dermatopharmacology fellowship at Icahn School of Medicine. She tells us about the unique journey that she took to both medical school and dermatology. This is an episode you won't want to miss as Dr. Pasumarthi gives great insight and advice no matter what point you are at in your medical training! We hope you enjoy! Get in touch with Dr. Pasumarthi: Anusha.pasumarthi@mssm.edu---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com---Music: "District Four" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 Licensehttp://creativecommons.org/licenses/by/4.0/

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Brad Hill, MD, discuss the following articles from the March 2025 issue: “Effect of Tourniquet-Related Nerve Ischemia on Response to Handheld Nerve Stimulation in Ulnar Nerve Transposition” by Brogan, Lee, Beamer, and Dy. “Eaton-Littler Ligament Reconstruction in Thumb Carpometacarpal Joint Instability: Outcomes and Prognostic Factors in 74 Patients” by Nieuwdrop, Jongen, Hundepool, et al. “Cost Comparison of Digital Nerve Repair Techniques” Hu, Williams, Kammien, et al. Special guest, Brad Hill, MD, completed combined residency training in General Surgery and Plastic and Reconstructive Surgery at New York University, followed by a Fellowship in Hand and Upper Extremity Surgery at the Curtis National Hand Center. Dr Hill currently serves as the Director of Hand and Peripheral Nerve Surgery Education at Vanderbilt University Medical Center. He is an avid educator and guest on several other national medical podcasts. READ the articles discussed in this podcast as well as free related content: https://bit.ly/March25JCCollection

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of neuroendocrine tumors of the small bowel. Learning Objectives: In this episode, we review the basics of neuroendocrine (NE) tumors of the small bowel, including how to evaluate patients with presenting symptoms consistent with NE tumors, initial work-up, staging, and management.  We discuss key concepts including DOTATATE scans and medical therapies high yield for direct patient care and board exams.  Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Links to Paper Referenced in this Episode: Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095. https://pubmed.ncbi.nlm.nih.gov/28076709/ ***SPECIALTY TEAM APPLICATION LINK: https://docs.google.com/forms/d/e/1FAIpQLSdX2a_zsiyaz-NwxKuUUa5cUFolWhOw3945ZRFoRcJR1wjZ4w/viewform?usp=sharing Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.

Join Patrick Georgoff to learn more about how YOU can make amazing digital education content. At Behind the Knife we are often asked how to create digital education content. Thanks to the democratization of technology and rise of the creator economy, all of the tools are at your fingertips. Would you like to enhance your next lecture, grant application, manuscript submission, or patient educational material? You can, even if you are part luddite! You don't need a publisher, advanced computer skills, or tons of money. Don't believe us? Listen to this short podcast for tipsand tricks on how you can make great content.  Patrick Georgoff (@georgoff) is an Acute Care Surgeon at Duke University. He went to medical school at the University of Pennsylvania, completed General Surgery residency and Surgical Critical Care fellowship at the University of Michigan, and a Trauma Surgery fellowship at the University of Texas in Houston. His clinical practice includes the full spectrum of Acute Care Surgery in addition to elective hernia surgery. Patrick is deeply involved in surgical education and the is the Associate Program of the General Surgery Residency at Duke and Co-Director of Behind the Knife. He is passionate about trauma system performance and holds the position of associate Trauma Medical Director at Duke.  ***SPECIALTY TEAM APPLICATION LINK: https://docs.google.com/forms/d/e/1FAIpQLSdX2a_zsiyaz-NwxKuUUa5cUFolWhOw3945ZRFoRcJR1wjZ4w/viewform?usp=sharing Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.

Independence Health System's General Surgery specialiist in bariatrics surgery in the Westmoreland Area, Dr. BenFauzi El-Attrache calls in to talk about changes going into the new year.

Guest: Dr. Christian de Virgilio is the Chair of the Department of Surgery at Harbor-UCLA Medical Center. He is also Co-Chair of the College of Applied Anatomy and a Professor of Surgery at UCLA's David Geffen School of Medicine. He completed his undergraduate degree in Biology at Loyola Marymount University and earned his medical degree from UCLA. He then completed his residency in General Surgery at UCLA-Harbor Medical Center followed by a fellowship in Vascular Surgery at the Mayo Clinic.   Resources:  Rutherford Chapters (10th ed.): 174, 175, 177, 178 Prior Holding Pressure episode on AV access creation: https://www.audiblebleeding.com/vsite-hd-access/ The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access: https://www.jvascsurg.org/article/S0741-5214%2808%2901399-2/fulltext  KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update: https://pubmed.ncbi.nlm.nih.gov/32778223/    Outline: Steal Syndrome Definition & Etiology Steal syndrome is an important complication of AV access creation, since access creation diverts arterial blood flow from the hand. Steal can be caused by multiple factors—arterial occlusive disease proximal or distal to the AV anastomosis, high flow through the fistula at the expense of distal arterial perfusion, and failure of the distal arterial networks to adapt to this decreased blood flow.  Incidence and Risk Factors The frequency of steal syndrome is 1.6-9%1,2, depending on the vessels and conduit choice Steal syndrome is more common with brachial and axillary artery-based accesses and nonautogenous conduits. Other risk factors for steal syndrome are peripheral vascular disease, coronary artery disease, diabetes, advanced age, female sex, larger outflow conduit, multiple prior permanent access procedures, and prior episodes of steal.3,4  Long-standing insulin-dependent diabetes causes both medial calcinosis and peripheral neuropathy, which limits arteries' ability to vasodilate and adjust to decreased blood flow. Patient Presentation, Symptoms, Grading Steal syndrome is diagnosed clinically.  Symptoms after AVG creation occurs within the first few days, since flow in prosthetic grafts tend to reach a maximum value very early after creation. Native AVFs take time to mature and flow will slowly increase overtime, leading to more insidious onset of symptoms that can take months or years. The patient should have a unilateral complaint in the extremity with the AV access. Symptoms of steal syndrome, in order of increasing severity, include nail changes, occasional tingling, extremity coolness, numbness in fingertips and hands, muscle weakness, rest pain, sensory and motor deficits, fingertip ulcerations, and tissue loss.  There could be a weakened radial pulse or weak Doppler signal on the affected side, and these will become stronger after compression of the AV outflow. Symptoms are graded on a scale specified by Society of Vascular Surgery (SVS) reporting standards:5  Workup Duplex ultrasound can be used to analyze flow volumes. A high flow volume (in autogenous accesses greater than 800 mL/min, in nonautogenous accesses greater than 1200 mL/min) signifies an outflow issue. The vein or graft is acting as a pressure sink and stealing blood from the distal artery. A low flow volume signifies an inflow issue, meaning that there is a proximal arterial lesion preventing blood from reaching the distal artery. Upper extremity angiogram can identify proximal arterial lesions. Prevention Create the AV access as distal as possible, in order to preserve arterial inflow to the hand and reduce the anastomosis size and outflow diameter.  SVS guidelines recommend a 4-6mm arteriotomy diameter to balance the need for sufficient access flow with the risk of steal. If a graft is necessary, tapered prosthetic grafts are sometimes used in patients with steal risk factors, using the smaller end of the graft placed at the arterial anastomosis, although this has not yet been proven to reduce the incidence of steal.  Indications for Treatment Intervention is recommended in lifestyle-limiting cases of Grade II and all Grade III steal cases. If left untreated, the natural history of steal syndrome can result in chronic limb ischemia, causing gangrene with loss of digits or limbs. Treatment Options Conservative management relies on observation and monitoring, as mild cases of steal syndrome may resolve spontaneously. Inflow stenosis can be treated with endovascular intervention (angioplasty with or without stent) Ligation is the simplest surgical treatment, and it results in loss of the AV access. This is preferred in patients with repetitive failed salvage attempts, venous hypertension, and poor prognoses. Flow limiting procedures can address high volumes through the AV access. Banding can be performed with surgical cutdown and placement of polypropylene sutures or a Dacron patch around the vein or graft. The Minimally Invasive Limited Ligation Endoluminal-Assisted Revision (MILLER) technique employs a percutaneous endoluminal balloon inflated at the AVF to ensure consistency in diameter while banding Plication is when a side-biting running stitch is used to narrow lumen of the vein near the anastomosis. A downside of flow-limiting procedures is that it is often difficult to determine how much to narrow the AV access, as these procedures carry a risk of outflow thrombosis. There are also surgical treatments focused on reroute arterial inflow. The distal revascularization and interval ligation (DRIL) procedure involves creation of a new bypass connecting arterial segments proximal and distal to the AV anastomosis, with ligation of the native artery between the AV anastomosis and the distal anastomosis of the bypass. Reversed saphenous vein with a diameter greater than 3mm is the preferred conduit. Arm vein or prosthetic grafts can be used if needed, but prosthetic material carries higher risk of thrombosis. The new arterial bypass creates a low resistance pathway that increases flow to distal arterial beds, and interval arterial ligation eliminates retrograde flow through the distal artery.  The major risk of this procedure is bypass thrombosis, which results in loss of native arterial flow and hand ischemia. Other drawbacks of DRIL include procedural difficulty with smaller arterial anastomoses, sacrifice of saphenous or arm veins, and decreased fistula flow. Another possible revision surgery is revision using distal inflow (RUDI). This procedure involves ligation of the fistula at the anastomosis and use of a conduit to connect the outflow vein to a distal artery. The selected distal artery can be the proximal radial or ulnar artery, depending on the preoperative duplex. The more dominant vessel should be spared, allowing for distal arterial beds to have uninterrupted antegrade perfusion. The nondominant vessel is used as distal inflow for the AV access. RUDI increases access length and decreases access diameter, resulting in increased resistance and lower flow volume through the fistula. Unlike DRIL, RUDI preserves native arterial flow.  Thrombosis of the conduit would put the fistula at risk, rather than the native artery.  The last surgical revision procedure for steal is proximalization of arterial inflow (PAI). In this procedure, the vein is ligated distal to the original anastomosis site and flow is re-established through the fistula with a PTFE interposition graft anastomosed end-to-side with the more proximal axillary artery and end-to-end with the distal vein. Similar to RUDI, PAI increases the length and decreases the diameter of the outflow conduit. Since the axillary artery has a larger diameter than the brachial artery, there is a less significant pressure drop across the arterial anastomosis site and less steal. PAI allows for preservation of native artery's continuity and does not require vein harvest.  Difficulties with PAI arise when deciding the length of the interposition graft to balance AV flow with distal arterial flow. 2. Ischemic Monomelic Neuropathy Definition Ischemic monomelic neuropathy (IMN) is a rare but serious form of steal that involves nerve ischemia. Severe sensorimotor dysfunction is experienced immediately after AV access creation. Etiology IMN affects blood flow to the nerves, but not the skin or muscles because peripheral nerve fibers are more vulnerable to ischemia. Incidence and Risk Factors IMN is very rare; it has an estimated incidence of 0.1-0.5% of AV access creations.6 IMN has only been reported in brachial artery-based accesses, since the brachial artery is the sole arterial inflow for distal arteries feeding all forearm nerves. IMN is associated with diabetes, peripheral vascular disease, and preexisting peripheral neuropathy that is associated with either of the conditions. Patient Presentation Symptoms usually present rapidly, within minutes to hours after AV access creation. The most common presenting symptom is severe, constant, and deep burning pain of the distal forearm and hand. Patients also report impairment of all sensation, weakness, and hand paralysis. Diagnosis of IMN can be delayed due to misattribution of symptoms to anesthetic blockade, postoperative pain, preexisting neuropathy, a heavily bandaged arm precluding neurologic examination. Treatment Treatment is immediate ligation of the AV access. Delay in treatment will quickly result in permanent sensorimotor loss.   3. Perigraft Seroma Definition A perigraft seroma is a sterile fluid collection surrounding a vascular prosthesis and is enclosed within a pseudomembrane. Etiology and Incidence Possible etiologies include: transudative movement of fluid through the graft material, serous fluid collection from traumatized connective tissues (especially the from higher adipose tissue content in the upper arm), inhibition of fibroblast growth with associated failure of the tissue to incorporate the graft, graft “wetting” or kinking during initial operation, increased flow rates, decreased hematocrit causing oncotic pressure difference, or allergy to graft material. Seromas most commonly form at anastomosis sites in the early postoperative period. Overall seroma incidence rates after AV graft placement range from 1.7–4% and are more common in grafts placed in the upper arm (compared to the forearm) and Dacron grafts (compared to PTFE grafts).7-9 Patient Presentation and Workup Physical exam can show a subcutaneous raised palpable fluid mass Seromas can be seen with ultrasound, but it is difficult to differentiate between the types of fluid around the graft (seroma vs. hematoma vs. abscess) Indications for Treatment Seromas can lead to wound dehiscence, pressure necrosis and erosion through skin, and loss of available puncture area for hemodialysis Persistent seromas can also serve as a nidus for infection. The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines10 recommend a tailored approach to seroma management, with more aggressive surgical interventions being necessary for persistent, infected-appearing, or late-developing seromas.   Treatment The majority of early postoperative seromas are self-limited and tend to resolve on their own Persistent seromas have been treated using a variety of  methods-- incision and evacuation of seroma, complete excision and replacement of the entire graft, and primary bypass of the involved graft segment only. Graft replacement with new material and rerouting through a different tissue plane has a higher reported cure rate and lower rate of infection than aspiration alone.9     4. Infection Incidence and Etiology The reported incidence of infection ranges 4-20% in AVG, which is significantly higher than the rate of infection of 0.56-5% in AVF.11  Infection can occur at the time of access creation (earliest presentation), after cannulation for dialysis (later infection), or secondary to another infectious source. Infection can also further complicate a pre-existing access site issue such as infection of a hematoma, thrombosed pseudoaneurysm, or seroma. Skin flora from frequent dialysis cannulations result in common pathogens being Staphylococcus, Pseudomonas, or polymicrobial species. Staphylococcus and Pseudomonas are highly virulent and likely to cause anastomotic disruption. Patient Presentation and Workup Physical exam will reveal warmth, pain, swelling, erythema, induration, drainage, or pus. Occasionally, patients have nonspecific manifestations of fever or leukocytosis. Ultrasound can be used to screen for and determine the extent of graft involvement by the infection.   Treatments In AV fistulas: Localized infection can usually be managed with broad spectrum antibiotics.  If there are bleeding concerns or infection is seen near the anastomosis site, the fistula should be ligated and re-created in a clean field. In AV grafts: If infection is localized, partial graft excision is acceptable. Total graft excision is recommended if the infection is present throughout the entire graft, involves the anastomoses, occludes the access, or contains particularly virulent organisms Total graft excision may also be indicated if a patient develops recurrent bacteremia with no other infectious source identified. For graft excision, the venous end of the graft is removed and the vein is oversewn or ligated. If the arterial anastomosis is intact, a small cuff of the graft can be left behind and oversewn. If the arterial anastomosis is involved, the arterial wall must be debrided and ligation, reconstruction with autogenous patch angioplasty, or arterial bypass can be pursued. References   1. Morsy AH, Kulbaski M, Chen C, Isiklar H, Lumsden AB. Incidence and Characteristics of Patients with Hand Ischemia after a Hemodialysis Access Procedure. J Surg Res. 1998;74(1):8-10. doi:10.1006/jsre.1997.5206 2. Ballard JL, Bunt TJ, Malone JM. Major complications of angioaccess surgery. Am J Surg. 1992;164(3):229-232. doi:10.1016/S0002-9610(05)81076-1 3. Valentine RJ, Bouch CW, Scott DJ, et al. Do preoperative finger pressures predict early arterial steal in hemodialysis access patients? A prospective analysis. J Vasc Surg. 2002;36(2):351-356. doi:10.1067/mva.2002.125848 4. Malik J, Tuka V, Kasalova Z, et al. Understanding the Dialysis access Steal Syndrome. A Review of the Etiologies, Diagnosis, Prevention and Treatment Strategies. J Vasc Access. 2008;9(3):155-166. doi:10.1177/112972980800900301 5. Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603-610. doi:10.1067/mva.2002.122025 6. Thermann F, Kornhuber M. Ischemic Monomelic Neuropathy: A Rare but Important Complication after Hemodialysis Access Placement - a Review. J Vasc Access. 2011;12(2):113-119. doi:10.5301/JVA.2011.6365 7. Dauria DM, Dyk P, Garvin P. Incidence and Management of Seroma after Arteriovenous Graft Placement. J Am Coll Surg. 2006;203(4):506-511. doi:10.1016/j.jamcollsurg.2006.06.002 8. Gargiulo NJ, Veith FJ, Scher LA, Lipsitz EC, Suggs WD, Benros RM. Experience with covered stents for the management of hemodialysis polytetrafluoroethylene graft seromas. J Vasc Surg. 2008;48(1):216-217. doi:10.1016/j.jvs.2008.01.046 9. Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts. Surgery. 1985;97(2):194-204. 10. Lok CE, Huber TS, Lee T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020;75(4):S1-S164. doi:10.1053/j.ajkd.2019.12.001 11. Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vasc Surg. 2008;48(5):S55-S80. doi:10.1016/j.jvs.2008.08.067

We discuss the recognition and treatment of necrotizing fasciitis. Hosts: Aurnee Rahman, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Necrotizing_Fasciitis.mp3 Download Leave a Comment Tags: Critical Care, General Surgery Show Notes Table of Contents 0:00 – Introduction 0:41 – Overview 1:10 – Types of Necrotizing Fasciitis 2:21 – Pathophysiology & Risk Factors 3:16 – Clinical Presentation 4:06 – Diagnosis 5:37 – Treatment 7:09 – Prognosis and Recovery 7:37 – Take Home points Introduction Necrotizing soft tissue infections can be easily missed in routine cases of soft tissue infection. High mortality and morbidity underscore the need for vigilance. Definition A rapidly progressive, life-threatening infection of the deep soft tissues. Involves fascia and subcutaneous fat, causing fulminant tissue destruction. High mortality often due to delayed recognition and treatment. Types of Necrotizing Fasciitis Type I (Polymicrobial) Involves aerobic and anaerobic organisms (e.g., Bacteroides, Clostridium, Peptostreptococcus). Common in immunocompromised patients or those with comorbid...

In this special series, core faculty members of the SVS Leadership Development Program, Dr. Manuel Garcia-Toca, Dr. Kenneth Slaw, and Steve Robischon, discuss the program origins, research regarding good leadership, and how to join.    Manuel Garcia-Toca, MD completed his MD at the Universidad Anahuac in Mexico (1999) and MS in Health Policy at Stanford University (2020). Dr. Garcia-Toca completed his residency in General Surgery at Brown University (2008) and a fellowship in Vascular Surgery at Northwestern University (2010). He will serve within the Department of Surgery in the Division of Vascular Surgery and Endovascular Therapy and the Division of Emory Surgery at Grady based primarily at Grady Memorial Hospital. Kenneth Slaw, PhD is the executive director of the Society for Vascular Surgeons.  Dr. Slaw received his master's and doctoral degrees in educational psychology from the University of Illinois. He has over 35 years of executive leadership experience in the medical society and philanthropic communities, having served in numerous previous roles, including as president of the American Association of Medical Society Executives, as chairman of the board of Make A Wish Illinois, and as senior staff member at the Academy of Pediatrics, where he assisted in efforts with the Pediatric Leadership Alliance Program, which has provided leadership skill building sessions for approximately 3, 000 physicians. Steve Robischon, PA-C is a Physician Assistant with the Division of Vascular and Endovascular Surgery at the Medical College of Wisconsin in Milwaukee, Wisconsin, and is also a member of the PA Section Steering Committee.   More about the SVS PA Section More about the SVS Leadership Program   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

In this episode of Girls with Grafts, we're honored to sit down with Dr. Tam Pham, the Program Director at the University of Washington Medicine Regional Burn Center. Dr. Pham opens up about his personal journey when he sustained a burn as a young child. Rachel and Dr. Pham discuss the topic of imposter syndrome among some burn survivors and caregivers, highlighting that while we may not all have physical scars, we do all carry emotional ones.Dr. Pham also shares the critical role of aftercare and support services in helping survivors reclaim their lives and thrive beyond their injuries. He also reflects on his connection with Grace Athena Flott, a local artist, fellow survivor, and former patient, whose powerful artwork he proudly displays in their burn clinic. This episode is a moving tribute to the resilience of the burn community, the power of support, and the art of turning pain into purpose. Don't miss this inspiring and heartfelt conversation!  ⭐️ Enjoyed the show? Tell us by leaving a 5-star review and sharing on social media using hashtag #GirlswithGrafts and tagging Phoenix Society for Burn Survivors!   Meet Our Guest Dr. Tam Pham is a highly accomplished surgeon specializing in burn and trauma care, with extensive academic and clinical experience. Currently, he is a professor and director of the University of Washington Medicine Regional Burn Center at Harborview Medical Center. A graduate of the University of California, Dr. Pham pursued rigorous postgraduate training, including a General Surgery residency, and fellowships in burn care and surgical critical care at the University of Washington. His academic contributions are significant, with numerous published research papers, including studies on critical care and telemedicine applications in burn care.Dr. Pham has also been honored with numerous awards and is dedicated to advancing burn care. He has volunteered internationally as well as holds board certifications and is a member of many professional organizations, including the American Burn Association. Links Watch Dr. Rob Cartotto's Girls with Grafts podcast episode on YouTube. Watch Grace Athena Flott's Girls with Grafts podcast episode on YouTube.Learn more about Grace's recent selection to create Governor Jay Inslee's official portrait.Learn more about Phoenix SOAR (Survivors Offering Assistance in Recovery).Podcast Sponsor Today's podcast is powered by the National Fire Sprinkler Association! NFSA aims to protect lives and property through the advancement of fire sprinklers. Learn more about fire sprinklers, fire advocacy, and how to get involved by visiting nfsa.org.  Sponsor Girls with Grafts  Interested in becoming a sponsor of the show? Email us at info@phoenix-society.org.  

Osteopathic education in surgery has undergone significant changes, especially with the transition to a single ACGME accreditation system in 2020. Despite initial concerns about equitable access and representation, studies have highlighted increasing competitiveness of osteopathic medical students in surgical residency matches and comparable outcomes between allopathic and osteopathic surgeons, affirming the quality of osteopathic training. In this episode, we talk with Dr. Kristen Conrad-Schnetz, recent president of the American College of Osteopathic Surgeons (ACOS) and General Surgery program director at Cleveland Clinic South Pointe Hospital, about osteopathy in general surgery. We delve into the role of osteopathic principles in surgical training and practice and the impact of transitioning to a single accreditation system. Dr. Conrad-Schnetz shares insights on overcoming misconceptions about DO surgeons and her vision for the future of osteopathic recognition in surgery.  Join hosts Pooja Varman MD, Judith French PhD, and Jeremy Lipman MD, MHPE for this exciting conversation with Kristen Conrad-Schnetz, DO.  Learning Objectives By the end of this episode, listeners will be able to  1.     List the four tenets of osteopathic medicine 2.     Identify how osteopathic principles and practices can be incorporated into surgical practice 3.     Explain the significance of osteopathic recognition in residency programs 4.     Discuss strategies for promoting equity for DO surgery residents References 1.  Williamson TK, Martinez VH, Ojo DE, et al. An analysis of osteopathic medical students applying to surgical residencies following transition to a single graduate medical education accreditation system. Journal of Osteopathic Medicine. 2024;124(2):51-59. doi:10.1515/jom-2023-0118 https://pubmed.ncbi.nlm.nih.gov/37921195/ 2.  Russell TA, Yoshida R, Men M, et al. Comparison of Outcomes for Patients Treated by Allopathic vs Osteopathic Surgeons. JAMA Surgery. Published online October 16, 2024. doi:10.1001/jamasurg.2024.4580 https://pubmed.ncbi.nlm.nih.gov/39412774/ 3.  Etheart I, Krise SM, Burns JB, Conrad-Schnetz K. The Effect of Single Accreditation on Medical Student Match Rates in Surgical Specialties. Cureus. 2021;13(4):e14301. doi:10.7759/cureus.14301 https://pubmed.ncbi.nlm.nih.gov/33968513/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a focus on cutaneous oncology and gastrointestinal stromal tumors (GIST). Learn more about Selected Readings in General Surgery, an American College of Surgeons publication that highlights highly relevant and practice-changing information from the world's most prominent medical journals. #SurgicalReadings #SRGS

الأطباء المصريين، الجراحة العامة والسمنة والهجرة الطبية. دكتور شريف حقى مع البودكاسترز هيكلمنا عن جراحات الجهاز الهضمى، جراحات السمنة بأنواعها و إيه أضرارها وفوائدها. كمان هنعرف منه إيه هى الهجرة الطبية ونصائح للأطباء الشباب والطلاب.

In this episode, M4's Kyle and Maddy talk through their experiences and advice on how to perform well in clerkships. They also discuss specifics for Internal Medicine, General Surgery, Pediatrics, OB/GYN, Family Medicine, and Psychiatry clerkships.Link to psych template: https://docs.google.com/document/d/1fxTFBdC0un-eqvvx9a9Y91taV06ES6OaNp1fFdew3Sk/edit?usp=sharing

In this episode, we review key components of the landmark MAGIC and FLOT-4 trials that investigated perioperative chemotherapy in the treatment of locally advanced gastric cancer.  We discuss limitations of both trials and the evolving clinical landscape of gastric cancer treatment. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist/HPB surgeon at Brooke Army Medical Center. - Daniel Nelson, DO, FACS (@usarmydoc24) is a Surgical Oncologist/HPB surgeon at Kaiser Permanente Los Angeles Medical Center. - Connor Chick, MD (@connor_chick) is a Surgical Oncology Senior Fellow at Ohio State. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology Junior Fellow at MD Anderson Cancer Center. - Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center.  Learning Objectives:  1.     Understand background, methodology, results, and interpretation of the MAGIC trial. 2.     Understand background, methodology, results, and interpretation of the FLOT trial. 3.     Be able to discuss the evolution of chemotherapeutic regimens in the treatment of locally advanced gastric cancer and rationale for their use. 4.     Be able to describe key limitations for the above regimens. 5.     Discuss the the evolving clinical landscape for chemotherapy in gastroesophageal junction tumors. Links to Papers Referenced in this Episode: Journal Articles: Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., ... & Chua, Y. J. (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine, 355(1), 11-20. https://pubmed.ncbi.nlm.nih.gov/16822992/ Al-Batran, S. E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., ... & Hofheinz, R. D. (2019). Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. The Lancet, 393(10184), 1948-1957. https://pubmed.ncbi.nlm.nih.gov/30982686/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Dennis received his B.Sc. and M. D. Degrees from the University of Alberta, and his MSc. Degree and training in General Surgery, Cardiovascular and Thoracic Surgery and Critical Care at McGill University, he spent 3 more years of training in transplantation immunology, heart and lung transplantation and high-risk cardiovascular surgery at Stanford University Medical Center. He implemented Western Canada's first heart and lung transplantation program and served as the Director of both the Heart and Lung Transplantation Program and Cardiovascular Intensive Care Unit for 20+ years. He spent 30 years as a practising doctor and is the former CEO of the Alberta Prosperity Project. We discuss Alberta's position in Canada, the pace of government and the Alberta first mindset.  Clothing Link:⁠⁠⁠https://snp-8.creator-spring.com/listing/the-mashup-collection⁠⁠ Text Shaun 587-217-8500 Substack:https://open.substack.com/pub/shaunnewmanpodcast E-transfer here: shaunnewmanpodcast@gmail.com Silver Gold Bull Links: Website: https://silvergoldbull.ca/ Email: SNP@silvergoldbull.com Text Grahame: (587) 441-9100

Welcome to FractureLine: the official weekly news feed from the Chest Wall Injury Society, where we will listen to all the bottom-line CWIS updates, shout-outs, fun facts, and weekly banter! This week's episode welcomes Dr. Chris Janowak, MD, FACS. He works in General Surgery and Surgical Critical Care at the VA and the University of Cincinnati Medical Center. Dr. Janowak discusses his research interests and his article "The Next Generation: Surgeon Learning Curve in a Mature Operative Rib Management Program." As always, SarahAnn, Dr. White, & Dr. Kryskow joined us. This episode will make you think and may even give you some research ideas!

About my Guest: Dr. Marcos de Andrade has devoted most of his life to the study of human potential, including a Bachelor's degree in Biology, Doctorate in Medicine, Master in Business Administration, and a research fellowship in General Surgery and the Metabolic Institute at the Cleveland Clinic. Dr. De and the Biohax medical team are known for contributing advanced studies, research and papers that continue to push the edges of medicine with profound, positive results. Dr. De founded Biohax because of his own personal journey where he learned to successfully bio-hack his systems in order to overcome a serious illness. From his personal wellness success, he self-funded and built the Biohax brand. Dr. De continues to expand the Biohax brand by doing global speaking engagements and educating the world about topics like epigenetics, human performance, longevity, hormone optimization, heart disease, and more. Social Handels: Podcast Instagram Youtube Facebook  Website Summary: In this episode of 'Back to the Basics', Dr. Cassie Smith and Dr. De discuss the importance of health and wellness in the modern world, focusing on environmental toxins and their impact on our health. Dr. De shares his personal journey into biohacking and functional medicine, emphasizing the significance of daily routines, exercise, and creating a healthy work environment. They delve into the effects of endocrine disruptors, the role of iodine in detoxification, and advanced health protocols to optimize well-being. The conversation concludes with practical tips for listeners to improve their health and nutrition. Time Stamps:  00:00 Introduction to Health and Wellness 02:50 Dr. De's Journey and Biohacks 06:10 Daily Routine and Health Practices 10:44 Creating a Healthy Work Environment 16:58 Understanding Environmental Toxins 22:46 The Impact of Endocrine Disruptors 36:20 The Role of Iodine and Detoxification 45:13 Advanced Health Protocols 53:14 Final Thoughts on Health and Nutrition Connect with Modern Endocrine: Check out the website Follow Cassie on Instagram Follow Cassie on Facebook Follow Cassie on YouTube Follow Cassie on TikTok Sign up for Modern Endocrine's newsletter Disclaimer 

Have you ever been confused about the concept of brain death, or struggled to explain brain death to a patient's family or your fellow clinicians? Join the Behind the Knife Surgical Palliative Care team and our special guest, neurologist & neurointensivist Dr. Sarah Wahlster, as we explore the 2023 Pediatric & Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline and what this updated guideline means for our practice in surgical palliative care! Hosts: Dr. Katie O'Connell (@katmo15) is an Associate Professor of Surgery at the University of Washington in the division of Trauma, Burn, and Critical Care Surgery. She is a trauma surgeon, palliative care physician, Director of Surgical Palliative Care, and founder of the Advance Care Planning for Surgery Clinic at Harborview Medical Center in Seattle, WA. Dr. Virginia Wang is a PGY-3 General Surgery resident at the University of Washington. Guest: Dr. Sarah Wahlster (@SWahlster) is an Associate Professor of Neurology at the University of Washington. She is a neurologist, neurointensivist, and Program Director of the Neurocritical Care Fellowship at Harborview Medical Center in Seattle, WA. Learning Objectives: ·      Understand the concept of assent and how it can be helpful in communicating with families of patients who have sustained brain death ·      Explain the main steps required for diagnosis of brain death (prerequisites, clinical exam, apnea testing, ancillary testing) ·      Understand key differences between the 2023 guideline and previous (2010 & 2011) guidelines ·      Be able to name the 3 accepted modalities of ancillary testing for brain death ·      Know basic communication best practices with families of patients who have sustained brain death from the surgical palliative care perspective (consistency of language & messaging; avoidance of phrases such as “life-sustaining treatment”, “comfort-focused measures”) References: 1.     Greer, D. M., Kirschen, M. P., Lewis, A., Gronseth, G. S., Rae-Grant, A., Ashwal, S., Babu, M. A., Bauer, D. F., Billinghurst, L., Corey, A., Partap, S., Rubin, M. A., Shutter, L., Takahashi, C., Tasker, R. C., Varelas, P. N., Wijdicks, E., Bennett, A., Wessels, S. R., & Halperin, J. J. (2023). Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline. Neurology, 101(24), 1112–1132. https://doi.org/10.1212/WNL.0000000000207740 2.     Lewis, A., Kirschen, M. P., & Greer, D. (2023). The 2023 AAN/AAP/CNS/SCCM Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guideline: A Comparison With the 2010 and 2011 Guidelines. Neurology. Clinical practice, 13(6), e200189. https://doi.org/10.1212/CPJ.0000000000200189 3.     AAN Interactive Brain Death/Death by Neurologic Criteria Evaluation Tool – https://www.aan.com/Guidelines/BDDNC 4.     AAN Brain Death/Death by Neurologic Criteria Checklist – https://www.aan.com/Guidelines/Home/GetGuidelineContent/1101 5.     Kirschen, M. P., Lewis, A., & Greer, D. M. (2024). The 2023 American Academy of Neurology, American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine Pediatric and Adult Brain Death/Death by Neurologic Criteria Determination Consensus Guidelines: What the Critical Care Team Needs to Know. Critical care medicine, 52(3), 376–386. https://doi.org/10.1097/CCM.0000000000006099 6.     Greer, D. M., Shemie, S. D., Lewis, A., Torrance, S., Varelas, P., Goldenberg, F. D., Bernat, J. L., Souter, M., Topcuoglu, M. A., Alexandrov, A. W., Baldisseri, M., Bleck, T., Citerio, G., Dawson, R., Hoppe, A., Jacobe, S., Manara, A., Nakagawa, T. A., Pope, T. M., Silvester, W., … Sung, G. (2020). Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA, 324(11), 1078–1097. https://doi.org/10.1001/jama.2020.11586 7.     Lele, A. V., Brooks, A., Miyagawa, L. A., Tesfalem, A., Lundgren, K., Cano, R. E., Ferro-Gonzalez, N., Wongelemegist, Y., Abdullahi, A., Christianson, J. T., Huong, J. S., Nash, P. L., Wang, W. Y., Fong, C. T., Theard, M. A., Wahlster, S., Jannotta, G. E., & Vavilala, M. S. (2023). Caseworker Cultural Mediator Involvement in Neurocritical Care for Patients and Families With Non-English Language Preference: A Quality Improvement Project. Cureus, 15(4), e37687. https://doi.org/10.7759/cureus.37687 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Yan Trokel, M.D. is a board certified surgeon specializing in facial aesthetic contouring. His areas of expertise include cosmetic facial surgery, endoscopic surgery, reconstructive surgery of the soft and hard tissues following cancer resection or trauma, orthognathic and craniofacial surgery.   Dr. Trokel is the Founder and Director of Y LIFT. He is a Fellow of the American Academy of Cosmetic Surgery; the American Association of Maxillofacial Surgeons; and the American Medical Association. Dr. Trokel also serves as a Facial Cosmetic Surgery Consultant in the Department of Maxillofacial Surgery at Mount Sinai Medical Center in New York, NY and Elmhurst Hospital in Queens, NY.   Dr.Trokel completed his undergraduate training and earned a Bachelor of Arts in Biology at Hofstra University. He then earned his Doctorate of Dental Surgery at Columbia University School of Dental & Oral Surgery where he was the recipient of many awards and honors of excellence, including the Percy T. Phillips Visiting Professional Scholar Award in 1996. Upon graduating Magna Cum Laude, Dr. Trokel was awarded membership in the National Dental Honors Society and was accepted to The University of Texas Southwestern Medical School and the prestigious Parkland Memorial Hospital program in Maxillofacial Surgery. Following his Medical Degree, Dr. Trokel then completed a rigorous internship in General Surgery. After earning his certificate in Maxillofacial Surgery, Dr. Trokel completed fellowship training in Cosmetic Surgery at the Willowbend Cosmetic Surgery Center under the direction of Dr. Stephen Watson.   Dr. Trokel has been featured in prominent publications, including Forbes Magazine, Harper's Bazaar, The New York Times Style Magazine, Town & Country Magazine, The Daily Mail and has made numerous T.V. and Radio appearances. He has collaborated and contributed to medical journals and research in aesthetic and reconstructive surgery and frequently lectures around the world on advanced facial rejuvenation surgery and other innovative technologies.

Our oral board review course includes 100 scenarios that meticulously cover 115 SCORE core topics. Each scenario includes two parts. The first part is a perfectly executed oral board scenario that mimics the real thing. Scenarios are 5 to 7 minutes long and include a variety of tactics and styles. If you are able to achieve this level of performance in your preparation you are sure to pass the oral exam with flying colors. The second part introduces high-yield commentary to each scenario. This commentary includes tips and tricks to help you dominate the most challenging scenarios in addition to practical, easy-to-understand teaching that covers the most confusing topics we face as general surgeons. We are confident you will find this unique, dual format approach a highly effective way to prepare for the test. All of our premium courses are available via our website and apps (iOS and Android).  Users can take notes, pin chapters and download content for offline viewing.   Learn more about the General Surgery Oral Board Review Course at https://app.behindtheknife.org/premium **Institutional Discounts Available - Please email hello@behindtheknife.org to learn more.** Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

  Absolutely! Here's the YouTube description for the new episode:

Please join us for a fascinating episode on Post-inflammatory hyperpigmentation with special guest Dr. Anifat Balogun. Postinflammatory hyperpigmentation is a skin condition characterized by the darkening of the skin following an inflammatory injury. Listen as Drs. Borger and Balogun dive into the intricacies of this common condition, and explore triggers, causes and current treatments. Anifat Balogun, received her Medical Doctorate degree from Drexel University College of Medicine in Philadelphia, PA, where she completed the Accelerated Psychiatry Program with Honors. She subsequently completed her General Surgery internship and Otolaryngology Head and Neck Surgery, Facial Plastic & Reconstructive Surgery residency at Albert Einstein College of Medicine, Montefiore Medical Center and Beth Israel Medical Center in New York, where she also completed additional training in Craniofacial Reconstructive Surgery as well as Congenital Disorders and Genetics. Her expertise is noninvasive, balanced and natural face and body rejuvenation, including the treatments and techniques to provide safe and effective treatments for patients with skin of color. In her clinical practice, Dr. Balogun has continued to train nationally and internationally and she brings her extensive knowledge about the scientific advancements in the field of Regenerative and Aesthetic Medicine to the daily care of her patients. She is a consultant and national trainer of expert neuromodulator (botox), dermal filler and PDO thread lift treatment techniques, with emphasis on utilizing minimally invasive injections techniques and combination procedures to achieve a natural, balanced and youthful look. Dr. Anifat Balogun Links: SkinMD Seattle Socials: https://www.instagram.com/seattleskinmd/ Facebook Page: https://www.facebook.com/SeattleSkinMD X (Twitter): https://twitter.com/skinmdseattle LinkedIn SkinMD Page: https://www.linkedin.com/company/skinmd-seattle-laser-&-aesthetic-medical-clinic/   Dr. Judith Borger Links: www.theaestheticdoctor.com www.instagram.com/doctorborger 

In this Father's Day Special, Mike interviews his old man about the state of point-of-care ultrasound in general surgery. All sorts of learning ensues. https://www.ultrasoundgel.org/162

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of gastric cancer. Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center - Connor Chick, MD (@connor_chick) is a Surgical Oncology fellow at Ohio State University. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-6 General Surgery resident at Brooke Army Medical Center - Beth (Elizabeth) Carpenter, MD (@elizcarpenter16) is a PGY-5 General Surgery resident at Brooke Army Medical Center Learning Objectives: In this episode, we review the basics of gastric cancer, including presentation, work-up, staging, and treatment modalities as well as high yield topics including the Siewert classification system. We also briefly discuss trials establishing peri-operative chemotherapy regimens for gastric cancer and the controversy of D1 vs. D2 lymphadenectomy. Links to Papers Referenced in this Episode Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. NEJM 2006 Jul;355(1):11-20. https://www.nejm.org/doi/full/10.1056/NEJMoa055531 Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesphageal junction adenocarcinoma (FLOT4): a randomized, phase2/3 trial Lancet 2019 May;393(10184):1948-1957. https://pubmed.ncbi.nlm.nih.gov/30982686/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Dr. Chrissy Guidry, after 4 years of medical school, completed 8 years of residency and fellowship training to become a Trauma Surgeon. She achieved double board certification in General Surgery and Critical Care Surgery. During her training, she often thought, "Once I get a job as a real doctor, I will be successful and then be happy." She believed that everything would be more fulfilling once she completed her training. However, a few years after finishing her training, she realized there was still something missing. She discovered that achieving happiness was a prerequisite for a successful career. Dr. Guidry learned that pursuing happiness is an intentional practice. Through studying and making active changes to her daily habits, she now experiences a life of abundant happiness, which she views as the true success in life. She now teaches this philosophy to her colleagues, believing that tapping into the best version of themselves enhances their ability to "docere" (from the Latin word meaning "to teach" and the root of the word "doctor") in their medical practice. Register to Honeymoon 2.0 Here: https://www.alexandrastockwell.com/honeymoon

Join the Behind the Knife Surgical Oncology Team as we discuss “One versus Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial,” the randomized trial guiding duration of imatinib treatment for gastrointestinal stromal tumors (GIST). Hosts: - Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center. - Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist and current HPB fellow at MD Anderson. - Connor Chick, MD (@connor_chick) is a Surgical Oncology fellow at Ohio State University. - Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-6 General Surgery resident at Brooke Army Medical Center. - Beth (Elizabeth) Carpenter, MD (@elizcarpenter16) is a PGY-5 General Surgery resident at Brooke Army Medical Center. Learning Objectives: In this episode, we discuss the article “One versus Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial” published in JAMA in 2012. This study demonstrated that 3 years of imatinib led to improved recurrence-free and overall survival compared to 1 year.   Links to Paper Referenced in this Episode https://jamanetwork.com/journals/jama/fullarticle/1105116  ***Fellowship Application - https://forms.gle/5fbYJ1JXv3ijpgCq9*** Please visit https://app.behindtheknife.org/home to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here https://app.behindtheknife.org/listen